Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.
| Name | Percentage | |
|---|---|---|
| Thryve | 100% | |
| FASTQ processed thru both Thryve and BiomeSight | 100% | |
| BiomeSightRdp | 91.3% | |
| Medivere | 91.3% | |
| BiomeSight | 87% | |
| CosmosId | 87% | |
| uBiome | 87% | |
| SequentiaBiotech | 87% | |
| Thorne | 82.6% | |
| es-xenogene | 82.6% | |
| AmericanGut | 82.6% | |
| Microba | 73.9% | |
| GanzimmunDiag | 65.2% | |
| Gut Zoomer (vibrant-wellness) | 43.5% | |
| Metagenomics Stool (De Meirleir) (16s Limited) | 34.8% | |
| DayTwo | 34.8% | |
| GanzImmun Diagnostic A6 (cfu/gm) | 26.1% | |
| Microba1 | 26.1% | |
| Genova Gi Effects (cfu/g) | 17.4% | |
| Diagnostic Solution GI-Map (cfu/gm) | 17.4% | |
| Biovis Microbiome Plus (cfu/g) | 13% | |
| GI EcologiX (Invivo) | 13% | |
| GI360 Stool (UK) | 13% | |
| NutriPATH | 13% | |
| Smart Gut (ubiome 16s - Limited Taxonomy) | 8.7% | |
| Nordic Laboratories | 8.7% | |
| InVitaLab (cfu/gm) | 8.7% | |
| Kyber Kompakt (cfu/g) | 8.7% | |
| Medivere: Darm Mikrobiom Stuhltest (16s limited) | 4.3% | |
| Medivere: Darn Magen Diagnostik (16s Limited) | 4.3% | |
| Medivere: Gesundsheitscheck Darm (16s Limited) | 4.3% | |
| Viome (Latest Reports Fail to provide ANY measurements) | 4.3% | |
| GanzImmun Diagnostics AG Befundbericht | 4.3% | |
| Bioscreen (cfu/gm) | 4.3% |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
